San Diego surgeons treat chronic brain bleeds through the blood vessels with a new coil
UC San Diego Health says it is the first West Coast health system to use a new coil that blocks the artery feeding chronic brain bleeds, a condition that is becoming more common as people age and take blood thinners.

Neurosurgeons at UC San Diego Health have used a new type of coil to seal off the artery that feeds chronic brain bleeds, the first health system on the West Coast to do so, the hospital said in a statement on 30 September. The team was also among the early adopters of a newly FDA-approved liquid agent that blocks the same blood vessels.
The condition is chronic subdural hematoma: blood that collects between the brain and its outer covering, often after a minor head injury. It is becoming more common as the population ages and more people take blood-thinning medication. Experts project it could become the most common cranial neurosurgical condition in adults by 2030, according to the hospital.
Doctors block the artery instead of only draining the blood
The standard treatment has long been surgery to drain the blood, but the bleeds often come back. In recent years, a procedure called middle meningeal artery (MMA) embolization has changed that. A doctor guides a thin tube through the blood vessels to the artery linked to the bleed and closes it, which helps keep the hematoma from returning.
Physicians can close the artery in two ways. Coils block blood flow mechanically, while liquid embolic materials can travel into smaller branches farther from the treatment site. The new coil is flexible enough to pass through small vessels and can treat a longer section of the artery than earlier coils, the hospital said.
David Santiago-Dieppa, the cerebrovascular and endovascular neurosurgeon who led the first procedure, said the patient treated with the new coil "is recovering well, which is encouraging as we continue to evaluate its potential." He also gave clinical input during the device's development.
A trial of 400 patients cut repeat surgeries by more than half
Evidence for the procedure itself comes from national clinical trials. In the EMBOLISE trial, published in the New England Journal of Medicine in 2024, 400 patients who needed surgery for a subacute or chronic subdural hematoma received either surgery alone or surgery plus MMA embolization. Within 90 days, the bleed came back or grew and required another operation in 4.1% of the embolization group, compared with 11.3% of those who had surgery alone.
The trial also found risks. Serious complications linked to the embolization occurred in four patients (2%), including two disabling strokes, and the authors wrote that further study of the procedure's safety is needed. The trial was funded by Medtronic. J. Scott Pannell, director of neurointerventional surgery at UC San Diego Health, was a site investigator.
“The growing body of evidence supporting MMA embolization has fundamentally changed how we approach chronic subdural hematoma.” — J. Scott Pannell, director of neurointerventional surgery, UC San Diego Health
One patient so far with the new coil
The hospital's announcement describes a single patient treated with the new coil, so there are no outcome data yet for this specific device. Researchers at UC San Diego developed a scoring system, called PACE, that measures how completely blood flow through the artery has been stopped after treatment; early research suggests more complete closure may be linked to better healing of the bleed. Simpler tools are changing diagnosis elsewhere; in New Zealand, a smartphone video of the neck is being tested as a heart check.
The release does not name the coil's manufacturer. Santiago-Dieppa and Pannell both disclosed that they are consultants to Stryker Corporation and Medtronic.
Not medical advice. This article reports on research and health programs for general information. Results from early studies often change in larger trials. Talk to a doctor before making decisions about your own health or treatment.
Sources
- UC San Diego Health · health.ucsd.edu
- nejm.org
How we choose and verify sources: editorial policy.











